Updates from a Phase I clinical trial examining ublituximab in combination with TGR-1202
Negative-data clinical trials in lymphoma presented at ASH 2015
The next steps for TGR-1202 and targeting the gene c-Myc
Panel discussion on the treatment of adolescent and young adult lymphoma patients
Catherine Bollard et al.
The potential clinical implications of targeted therapies for DLBCL and why the situation is complex